Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

IFOSFAMIDE vs MELPHALAN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

IFOSFAMIDE vs MELPHALAN: Safety Overview

Metric IFOSFAMIDE MELPHALAN
Total FAERS Reports 17,004 16,061
Deaths Reported 3,365 3,369
Death Rate 19.8% 21.0%
Hospitalizations 5,230 4,615
Average Patient Age 36.2 yrs 48.1 yrs
% Female Patients 41.7% 43.8%
FDA Approval Date Apr 4, 2007 Approved Prior to Jan 1, 1982
Manufacturer Baxter Healthcare Corporation Dr.Reddy's Laboratories Inc
Route INTRAVENOUS INTRAVENOUS
Marketing Status Prescription Discontinued